About Molecular Discovery
Molecular Discovery is a company based in Borehamwood (United Kingdom) founded in 1984 by Peter Goodford. It operates as a SaaS and B2B. Molecular Discovery offers products and services including MetaSite, MoKa, BioGPS, and GRID. Molecular Discovery operates in a competitive market with competitors including Insitro, HotSpot Therapeutics, Certara, TOLREMO therapeutics and Inpharmatica, among others.
- Headquarter Borehamwood, United Kingdom
- Founders Peter Goodford
- SectorsTechnologyHealthcare
- Website moldiscovery.com
- Social X
- Legal Name Molecular Discovery Ltd.
Products & Services of Molecular Discovery
Molecular Discovery offers a comprehensive portfolio of products and services, including MetaSite, MoKa, BioGPS, and GRID.
Predicts drug metabolism via Cytochrome P450 analysis.
Predicts pKa, logP, and solubility for compounds.
Facilitates pocket comparison for off-target predictions.
Describes molecular fields for drug design simulations.
People of Molecular Discovery
2 people are tracked at Molecular Discovery (2 in leadership).
| Name | Role | Group |
|---|---|---|
Peter Goodford | Founder | Leadership |
Francesco Cruciani | President/CEO/COO | Leadership |
Complete people profiles for Molecular Discovery
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Molecular Discovery
Molecular Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, HotSpot Therapeutics, Certara, TOLREMO therapeutics and Inpharmatica, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| hotspotthera.com | 2017 | Boston, United States | $210M | 37 | Developer of a platform for protein function analysis | |
| certara.com | 2008 | Princeton, United States | – | 827 | Provider of a platform for in silico drug discovery and consulting services | |
| tolremo.com | 2017 | Zurich, Switzerland | $55.81M | – | Anti-cancer small molecules are developed to target drug resistance pathways. | |
| inpharmatica.co.uk | 1998 | London, United Kingdom | – | 62 | Developer of predictive informatics based platform for drug discovery | |
| cytoreason.com | 2016 | Haifa, Israel | $100M | – | Immune system-based drugs are discovered via biological data analytics. | |
| grobio.com | 2016 | Boston, United States | $91.15M | 22 | Synthetic biology tools are developed via genetic code recoding techniques. | |
| c4xdiscovery.com | 2008 | Manchester, United Kingdom | – | 46 | Developer of optimized drug discovery and design services | |
| recludixpharma.com | 2020 | San Diego, United States | $60M | 33 | Provider of the online platform for drug discovery and development | |
| oxforddrugdesign.com | 2001 | Oxford, United Kingdom | $9.98M | 9 | Provider of computer-aided design of antibiotics for MDR infections |
Detailed competitors of Molecular Discovery
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Molecular Discovery
Websites that share an audience with Molecular Discovery (moldiscovery.com).
Websites whose visitors overlap most with Molecular Discovery. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| simulations-plus.com | 100% | 22.8K | #1,161,740 | View details | |
| chemaxon.com | 82% | 102.7K | #344,948 | View details | |
| gaussian.com | 75% | 89.7K | #435,583 | View details | |
| acdlabs.com | 70% | 177.1K | #258,053 | View details |
Latest news on Molecular Discovery
Complete news archive for Molecular Discovery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Molecular Discovery
10 companies that operate in the same segment as Molecular Discovery (Natural User Interface & Assistive Systems), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Customized HMI products including switches and joysticks are manufactured. | 1952 | Vista, California, United States | – | – | – | |
Developer of next-generation autonomous technologies for defense, aerospace, and commercial | 2012 | Poway, California, United States | – | – | – | |
A technology company that provided communication services and has been permanently closed. | 2016 | Indore, Madhya Pradesh, India | USD 1.72 M | USD 90.68 K | – | |
Global UX design company offering innovative solutions for automotive, financial, and retail industries. | 2009 | Pune, Maharashtra, India | – | USD 7.2 M | 147 | |
Provider of brain science and neural interface technology platform | – | Shanghai, China | USD 27.51 M | – | – | |
Offers personal assistant apps for smartphones and smart wearable devices. | 2007 | Hyderabad, Telangana, India | USD 2.5 M | – | – | |
Offers development, implementation and testing services for NUI sector | 1991 | Taipei, Taiwan | – | – | – | |
AI-based neurotechnology services are provided by Optios. | 2016 | San Diego, California, United States | USD 7.85 M | – | – | |
Smart data capture solutions are provided for various industries. | 2003 | Łodz, Łodz Voivodeship, Poland | – | – | – | |
Provider of innovation & scientific research and developing edge technology services | 1990 | Montreal, Quebec, Canada | – | – | 74 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Molecular Discovery
Molecular Discovery was founded in 1984.
Molecular Discovery is headquartered in Borehamwood, United Kingdom. It is registered at Borehamwood, Hertfordshire, United Kingdom.
Molecular Discovery Ltd. develops software using molecular interaction fields for drug discovery processes, including hit finding and lead optimization. Their tools predict pharmacokinetic properties like pKa and solubility, aiding pharmaceutical research. Products such as MetaSite and MoKa enable metabolism and physicochemical predictions. The company focuses on improving drug design decisions through scientific simulations, serving the biotech industry with advanced modeling capabilities.
Molecular Discovery's top competitors include Insitro, HotSpot Therapeutics and Certara.
Molecular Discovery offers MetaSite, MoKa, BioGPS, and GRID.
Molecular Discovery operates through Molecular Discovery Ltd..